Nonalcoholic Steatohepatitis Enrolling by Invitation Phase 2 Trials for Cenicriviroc (DB11758)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03059446Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic SteatohepatitisTreatment